The End Of Google's Reign Is Near Part I

There's no denying Google's dominance since its 2004 IPO, but the end of this juggernaut's growth story is here. Investors looking for life-changing returns must look elsewhere, and the best place for growth is in biotech. New technologies are allowing for more drugs to be synthesized and approved faster than ever, and with a large and growing market, the opportunities seem endless.

The NASDAQ has made its triumphant return to 5000, but much has changed since the dot-com bubble 15 years ago.

So, why is 2015 nothing like 2000? You've likely heard the tale already, “Today's NASDAQ valuation is supported by strong balance sheets and companies that actually generate earnings.”

In fact, I told a similar tale just a couple weeks ago. But that's not the entire story.

I'd even go as far as to argue that the current NASDAQ is nothing like we saw 10 years ago. First, let's talk a little about Google (NASDAQ: GOOGL).

Google's driverless cars, failed Google Glass and other ventures have all been funded by revenues from search related ads. But now those billions of dollars of search revenues are in serious jeopardy. Something we did a  deep dive into last week.

When Google hit the internet scene in 2004, it was the Wild West out there. Search was new and innovation in computing was everyone's focus.

With that, it's been a great 10-year run.

But 2014 appears to have been a watershed moment for Google, marking its top and signaling an end to its reign.

And so it's time for the likes of Google to step aside for the new leaders of the NASDAQ, a changing of the guard if you will.